SubHero Banner
Text

3rd Quarter 2023

Key topics in this quarter’s edition include:

  • Tirzepatide for chronic weight management
  • Donanemab for Alzheimer’s disease
  • Exagamglogene autotemcel and lovotibeglogene autotemcel for sickle cell disease

Download PDF